Either the content you're seeking doesn't exist or it requires proper authentication before viewing.
ISCT Mesenchymal Stroma Cell (MSC) Committee Mesenchymal stromal cells (MSCs) are among the most widely used cellular products worldwide, yet the field still lacks shared, testable answers about what happens to these cells after they are administered/delivered. ...
Andrew Haskell, PhD, MLS, CT(ASCP), CMM, BCM, QLSCM ISCT North America LRA Committee ASPR United States Lynn Csontos, RAC ISCT North America LRA Committee STEMCELL Technologies Canada Kevin Bosse, PhD, RAC-US, CABP(H) Chair, ISCT North America ...
Fajar Dumadi, BSc ISCT Canada Committee for Advanced Therapies (CAT) Agendas for recent meetings Agenda for the meeting on 18-20 March 2026 https://www.ema.europa.eu/en/documents/agenda/agenda-cat-meeting-18-20-march-2026_en.pdf ...
Mirja Krause-Onwukwe, PhD, MSc ISCT ANZ LRA Committee Member Australia Gabrielle O'Sullivan, PhD ISCT ANZ LRA Committee Co-Chair Australia Australia and New Zealand Regulatory Updates Medsafe Medsafe Guidance on Advanced Therapies ...
Fajar Dumadi, BSc Specialist, Regulatory Program ISCT Canada With great excitement, the International Society for Cell & Gene Therapy (ISCT) publishes its fifth Global Regulatory Report in collaboration with Clarivate ™. This report offers ...